Document is current
Any future updates will be listed below
-
Authors
Sir Karakus, Gozde
Tastan, Cihan
Dilek Kancagi, Derya
Yurtsever, Bulut
Tumentemur, Gamze
Demir, Sevda
Turan, Raife Dilek
Abanuz, Selen
Cakirsoy, Didem
Seyis, Utku
Ozer, Samed
Elibol, Omer
Elek, Muhammer
Ertop, Gurcan
Arbak, Serap
Acikel Elmas, Merve
Hemsinlioglu, Cansu
Kocagoz, Ayse Sesin
Hatirnaz Ng, Ozden
Akyoney, Sezer
Sahin, Ilayda
Ozbek, Ugur
Telci, Dilek
Sahin, Fikrettin
Yalcin, Koray
Ratip, Siret
Ovali, Ercument
-
Funding
Funding for this research was provided by:
Acibadem Healthcare Group
TÜBİTAK 2247-C Trainee Researcher Scholarship Program
TUBITAK-BIDEB 2244-University-Industry PhD program (118C082, 118C082)
- License Information
-
More Information
Article History
Received: 6 October 2020
Accepted: 4 February 2021
First Online: 11 March 2021
Competing interests
: G.S.K., C.T., D.D.K., B.Y., S.D., Dilek Telci, and F.S. are inventors of patent applications (pending) including “A Method For The Production Of Fast, Inclusive And High-Dose Inactive Vaccine For Use Against SARS-CoV-2 Virus” (2020/13279) and “A Fast, Inclusive And High-Dose Inactive Method For Adjuvant Positive Vaccination To Be Used Against SARS-CoV-2 Virus” (2020/14033) at Turkish Patent and Trademark Office. No other author has a competing interest except for these authors.
